59303-17-2

• 常用中文名：2-甲酰基-5-甲基噻唑
• 常用英文名：1-(5-Methyl-1,3-thiazol-2-yl)ethanone
• CAS号：59303-17-2
• 分子式：C₆H₇NOS
• 分子量：141.191
• 发布时间：2018-05-10 08:00:00
• 更新时间：2025-09-15 15:24:48

名称

• 中文名: 2-甲酰基-5-甲基噻唑
• 英文名: 1-(5-methyl-1,3-thiazol-2-yl)ethanone
• 英文别名: 1-(5-Methyl-1,3-thiazol-2-yl)ethanone; 1-(5-Methyl-1,3-thiazol-2-yl)-1-ethanone; Thiazole,2-acetyl-4-methyl; 1-(5-Methyl-thiazol-2-yl)-aethanon; Ethanone, 1-(5-methyl-2-thiazolyl)-; 2-acetyl-5-methylthiazole; 1-(5-Methylthiazol-2-yl)ethanone; 5-methyl-2-acetylthiazole

物化性质

• 密度: 1.2±0.1 g/cm3
• 沸点: 233.9±33.0 °C at 760 mmHg
• 分子式: C₆H₇NOS
• 分子量: 141.191
• 闪点: 95.3±25.4 °C
• 精确质量: 141.024841
• PSA: 58.20000
• LogP: 0.83
• 蒸汽压: 0.1±0.5 mmHg at 25°C
• 折射率: 1.539
• 储存条件: 2-8°C， 惰性气体

安全

• 危害码 (欧洲): Xn
• 海关编码: 2934100090

合成路线

78191-00-1 ~83% 59303-17-2

文献：KIRIN BEER KABUSHIKI KAISHA Patent: EP1535910 A1, 2005 ; Location in patent: Page/Page column 24-25 ; EP 1535910 A1

3581-89-3 68-12-2 ~% 59303-17-2

文献：COMENTIS, INC.; ASTELLAS PHARMA INC.; BILCER, Geoffrey, M.; DEVASAMUDRAM, Thippeswamy; LILLY, John, C.; ANKALA, Sudha, V.; MOSKALEV, Nikolai, V.; LIU, Chunfeng; INOUE, Makoto; KAWAKAMI, Shimpei; MUNAKATA, Ryosuke; HAMAJIMA, Toshihiro Patent: WO2012/54510 A1, 2012 ; Location in patent: Page/Page column 85-86 ; WO 2012/054510 A1

3581-89-3 78191-00-1 ~% 59303-17-2

文献：Farmer, Luc J.; Bemis, Guy; Britt, Shawn D.; Cochran, John; Connors, Martin; Harrington, Edmund M.; Hoock, Thomas; Markland, William; Nanthakumar, Suganthini; Taslimi, Paul; Haar, Ernst Ter; Wang, Jian; Zhaveri, Darshana; Salituro, Francesco G. Bioorganic and Medicinal Chemistry Letters, 2008 , vol. 18, # 23 p. 6231 - 6235

3581-89-3 925-90-6 ~% 59303-17-2

文献：Metzger; Koether Bulletin de la Societe Chimique de France, 1953 , p. 702,705

上下游产品

上游产品  4
78191-00-1 3581-89-3 68-12-2 925-90-6
下游产品  1
921145-14-4

海关

海关编码	2934100090
中文概述	2934100090. 结构上含有一个非稠合噻唑环的化合物(不论是否氢化). 增值税率:17.0%. 退税率:9.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0%
申报要素	品名, 成分含量, 用途
Summary	2934100090 other compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structure VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:20.0%